Review of IMS Health undertakings
The Competition Commission has decided against varying or removing undertakings which restrict the way in which IMS Health Incorporated sells its specialized pharmaceutical data services.
Administrative timetable
- Published on 18 October 2013 as required by Rule 6 of the Competition Commission Rules of Procedure. Any revisions made to the timetable will be published on this website.
Phase 2 | Action |
---|---|
6 August 2013 | OFT’s advice sent to the CC |
13 September 2013 | Deadline for consultation on OFT’s advice |
September to November 2013 | Consideration of OFT’s advice, responses to consultation and further CC assessment |
December 2013 | Publish provisional decision on change of circumstances and, as appropriate, a Notice of proposal to release or vary the undertakings |
January 2014 | Consideration of responses to provisional decision |
February 2014 | Publish final decision and, as appropriate, a Notice of release or variation of the undertakings |
Phase 2
Date of referral: 06/08/2013
Background information
News releases
- CC invites evidence on pharmaceutical data undertakings (16.08.13)
- CC set to keep pharmaceutical data undertakings in place (23.12.13)
- CC keeps pharmaceutical data undertakings in place (26.03.14)
Core documents
- Review Group: Martin Cave (Chairman of the Group); Katherine Holmes Jon Stern
- Administrative timetable (PDF, 23 Kb)
- Provisional decision (PDF, 317 Kb) (23.12.13)
- Final decision (PDF, 844 Kb) (26.03.14)
Phase 1
IMS Health undertakings review
Affected market: Pharmaceutical Data Services **No. ME/0139/98
Report to CC
Download the OFT’s advice to the CC